Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients

被引:45
|
作者
Shang, Da [1 ]
Xie, Qionghong [1 ]
Ge, Xiaolin [1 ]
Yan, Huanqing [2 ]
Tian, Jing [1 ]
Kuang, Dingwei [1 ]
Hao, Chuan-Ming [1 ]
Zhu, Tongying [1 ,2 ]
机构
[1] Fudan Univ, Huashan Hosp, Div Nephrol, Shanghai 200040, Peoples R China
[2] Fudan Univ, Huashan Hosp, Baoshan Branch, Div Nephrol, Shanghai 200443, Peoples R China
关键词
Coronary artery calcification; Peritoneal dialysis; Hyperphosphatemia; ESRD; CHRONIC KIDNEY-DISEASE; VASCULAR CALCIFICATION; MINERAL METABOLISM; MAINTENANCE HEMODIALYSIS; AORTIC CALCIFICATION; CARDIOVASCULAR RISK; MORTALITY; PHOSPHATE; CALCIUM; SCORE;
D O I
10.1186/s12882-015-0103-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Coronary artery calcification (CAC) is associated with cardiovascular mortality in end-stage renal disease (ESRD) patients. The present study aimed to identify modifiable risk factors for CAC progression in peritoneal dialysis (PD) patients. Methods: Adult patients who received regular PD for more than 6 months and underwent a series of coronary artery calcification score (CaCS) measurements by multislice spiral computed tomography (MSCT) with an interval of >= 6 months were included in this observational cohort study. The demographic characteristics and clinical data, including laboratory data and adequacy of PD, were collected. Curve estimation was used to fit the straight line and obtain the slope. Binary logistic regression was performed to identify the independent risk factors for CAC progression in the PD patients, and multivariate linear regression was conducted to identify factors associated with hyperphosphatemia. Results: A total of 207 adult patients on PD (116 men, 56.0 %) with a mean age of 59.8 +/- 15.9 years were recruited to this study, and 157 of them (75.8 %) received three or more CaCS assessments. The patients were divided into a slow group (n = 137) and a rapid group (n = 70) according to the linear regression slope or the average speed of development. The follow-up time was 33.0 +/- 18.8 months. Multivariate logistic regression revealed that age and serum phosphate level were independent risk factors for CAC progression after adjustments. Multivariate linear regression revealed that hyperphosphatemia was associated with elevations in the transferrin and serum albumin levels and normalized protein catabolic rate (nPCR) and reductions in the hemoglobin level, residual Ccr, and PD Ccr. Conclusions: Hyperphosphatemia is an independent risk factor for CAC progression, and the serum phosphate level may be associated with protein intake and PD adequacy. These results provide important information for the clinical management of ESRD patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients
    Da Shang
    Qionghong Xie
    Xiaolin Ge
    Huanqing Yan
    Jing Tian
    Dingwei Kuang
    Chuan-Ming Hao
    Tongying Zhu
    [J]. BMC Nephrology, 16
  • [2] Hyperphosphatemia and hs-CRP Initiate the Coronary Artery Calcification in Peritoneal Dialysis Patients
    Shang, Da
    Xie, Qionghong
    Shang, Bin
    Zhang, Min
    You, Li
    Hao, Chuan-Ming
    Zhu, Tongying
    [J]. BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [3] The effects of dialysis modalities on the progression of coronary artery calcification in dialysis patients
    Niu, Qingyu
    Zhao, Huiping
    Zuo, Li
    Wang, Mei
    Gan, Liangying
    [J]. BMC NEPHROLOGY, 2020, 21 (01)
  • [4] Trends in coronary artery calcification in peritoneal dialysis and transplant patients
    Stompór, T
    Pasowicz, M
    Sulowicz, W
    Dembinska-Kiec, A
    Tracz, W
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (12) : 3205 - 3206
  • [5] The effects of dialysis modalities on the progression of coronary artery calcification in dialysis patients
    Qingyu Niu
    Huiping Zhao
    Li Zuo
    Mei Wang
    Liangying Gan
    [J]. BMC Nephrology, 21
  • [6] Coronary Artery Calcification in Hemodialysis and Peritoneal Dialysis
    Jansz, Thijs T.
    van Reekum, Franka E.
    Ozyilmaz, Akin
    de Jong, Pim A.
    Boereboom, Franciscus T. J.
    Hoekstra, Tiny
    Verhaar, Marianne C.
    van Jaarsveld, Brigit C.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2018, 48 (05) : 369 - 377
  • [7] BASELINE AND CORONARY ARTERY CALCIFICATION PROGRESSION MODULATES THE RISK OF DEATH IN INCIDENT TO DIALYSIS PATIENTS
    Bellasi, Antonio
    Di Lullo, Luca
    Russo, Domenico
    Ratti, Carlo
    Cozzolino, Mario Gennaro
    Di Iorio, Biagio Raffaele
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [8] Coronary artery calcification, coronary artery stenosis and hyperphosphatemia in hemodialysis patients
    Patsalas, Stavros
    Eleftheriadis, Theodoros
    Theodoroglou, Hariklia
    Antoniadi, Georgia
    Liakopoulos, Vassilis
    Vargemezis, Vassilis
    [J]. THERAPEUTIC APHERESIS AND DIALYSIS, 2007, 11 (01) : 81 - 81
  • [9] Trends in coronary artery calcification in peritoneal dialysis and transplant patients - Reply
    Moe, SM
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (12) : 3206 - 3206
  • [10] Nonthyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis?
    Meuwese, Christiaan L.
    Carrero, Juan J.
    Cabezas-Rodriguez, Ivan
    Heimburger, Olof
    Barany, Peter
    Lindholm, Bengt
    Qureshi, Abdul R.
    Ripsweden, Jonaz
    Dekker, Friedo W.
    Stenvinkel, Peter
    [J]. JOURNAL OF INTERNAL MEDICINE, 2013, 274 (06) : 584 - 593